A quickie from Fierce Biotech this morning. Apparently, the Amgen-Onyx acquisition is no sooner announced than we're already talking about potential layoffs with 30 days after the deal officially closes. Given that analysts believe that Amgen primarily purchased Onyx for Kyprolis and other parts of its pipeline and not for its R&D staff per se -- this would seem to confirm that the Onyx staff can expect to take a haircut shortly after this deal officially closes. If they time it right, may be right in time for Xmas. Ouch!
Posted by Bruce Lehr Aug 28th 2013.